|
End-of-day quote
Shanghai S.E.
23/10/2026
|
5-day change | 1st Jan Change | ||
| 3.300 CNY | +1.23% |
|
-4.35% | -17.09% |
| Market Cap | 2.59B 388M 347M 320M 290M 543M 36.84B 552M 3.85B 1.53B 19.3B 1.46B 1.43B 60.85B | P/E 2024 |
-8.86x | P/E 2025 | -9.48x |
|---|---|---|---|---|---|
| Enterprise Value | 2.81B 421M 376M 347M 314M 588M 39.93B 598M 4.18B 1.65B 20.92B 1.58B 1.54B 65.96B | EV / Sales 2024 |
1.48x | EV / Sales 2025 | 1.79x |
| Free-Float |
69.26% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.23% | ||
| 1 week | -4.35% | ||
| Current month | -9.34% | ||
| 1 month | -10.08% | ||
| 3 months | -7.04% | ||
| 6 months | -27.47% | ||
| Current year | -17.09% |
| 1 week | 3.11 |  | 3.47 |
| 1 month | 3.11 | | 3.7 |
| Current year | 2.85 | | 5.27 |
| 1 year | 2.85 | | 5.27 |
| 3 years | 2.76 | | 6.15 |
| 5 years | 2.76 | | 8.8 |
| 10 years | 2.76 | | 20.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ya Qi Dou
CEO | Chief Executive Officer | 42 | 12/05/2021 |
Xianti Zeng
DFI | Director of Finance/CFO | 52 | 05/09/2024 |
Zhi Wei Wang
PRN | Corporate Officer/Principal | 56 | 16/09/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Ling Dou
CHM | Chairman | 66 | 21/01/2009 |
Zhi Wei Wang
BRD | Director/Board Member | 56 | 20/02/2011 |
Ya Qi Dou
BRD | Director/Board Member | 42 | 02/01/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.23% | -4.35% | -23.79% | -39.00% | 383M | |
| -2.54% | +1.31% | +55.10% | +120.84% | 1,165B | |
| -1.42% | +3.23% | +37.07% | +74.26% | 645B | |
| +0.16% | +0.08% | +25.14% | +97.36% | 504B | |
| -0.31% | +3.09% | +43.92% | +64.55% | 380B | |
| -1.34% | -0.47% | +66.63% | +40.56% | 363B | |
| -0.68% | +2.65% | +22.46% | +51.48% | 297B | |
| -1.20% | +3.04% | +2.62% | +26.97% | 269B | |
| -1.79% | +1.57% | +49.97% | +60.87% | 237B | |
| -0.73% | -0.10% | +29.24% | +101.19% | 195B | |
| Average | -0.48% | +1.70% | +30.84% | +59.91% | 405.59B | |
| Weighted average by Cap. | -0.25% | +2.67% | +41.07% | +82.27% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.17B 326M 291M 269M 244M 456M 30.94B 463M 3.24B 1.28B 16.21B 1.22B 1.2B 51.11B | 1.86B 279M 249M 230M 209M 391M 26.51B 397M 2.77B 1.1B 13.89B 1.05B 1.03B 43.79B |
| Net income | -317M -47.56M -42.47M -39.23M -35.55M -66.52M -4.51B -67.62M -472M -187M -2.37B -178M -175M -7.46B | -330M -49.41M -44.12M -40.76M -36.94M -69.11M -4.69B -70.25M -490M -194M -2.46B -185M -181M -7.75B |
| Net Debt | 411M 61.6M 55.01M 50.82M 46.05M 86.16M 5.85B 87.58M 612M 242M 3.06B 231M 226M 9.66B | 217M 32.55M 29.07M 26.85M 24.33M 45.53M 3.09B 46.28M 323M 128M 1.62B 122M 120M 5.1B |
Employees
4,832
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/10/26 | CN¥3.300 | +1.23% | 17,622,787 |
| 22/10/26 | CN¥3.260 | -3.83% | 13,819,303 |
| 21/10/26 | CN¥3.390 | +0.30% | 11,681,200 |
| 20/10/26 | CN¥3.380 | 0.00% | 11,732,000 |
| 19/10/26 | CN¥3.380 | -2.03% | 17,583,406 |
- Stock Market
- Stocks
- 600594 Stock
Select your edition
All financial news and data tailored to specific country editions
